69 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Kelly
    Kelly
  7. Keohan
    Keohan
  8. Qin
    Qin
  9. Antonescu
    Antonescu
  10. Singer
    Singer

Groups

  1. Department of Medicine (69)
  2. Sarcoma Service (69)
  3. Solid Tumor Oncology Division (69)
  4. Hematologic Malignancies, Division of (27)
  5. GSK Faculty (25)
  6. Human Oncology and Pathogenesis Program (22)
  7. Tow Center for Developmental Oncology (TCDO) (22)
  8. Surgery (16)
  9. Epidemiology and Biostatistics (11)
  10. Biostatistics Service (10)
  1. "2019"
  2. "Sarcoma Service"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (23)
  3. Review (2)
  4. Book Section (1)
  5. Book Whole (1)
  6. Editorial (1)
  7. Miscellaneous (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (69)
  2. Sarcoma Service (69)
  3. Solid Tumor Oncology Division (69)
  4. Hematologic Malignancies, Division of (27)
  5. GSK Faculty (25)
  6. Human Oncology and Pathogenesis Program (22)

More Groups

People
  1. William Tap (31)
  2. Sandra D'Angelo (24)
  3. Mrinal Gounder (18)
  4. Mark Dickson (13)
  5. Ping Chi (13)
  6. Cristina Antonescu (10)

More People

Years
  1. 2019 (69)
Publications
  1. Journal of Clinical Oncology (20)
  2. Annals of Oncology (8)
  3. Journal for ImmunoTherapy of Cancer (5)
  4. Journal of Oncology Practice (3)
  5. Journal of Thoracic Oncology (2)
  6. Molecular Cancer Therapeutics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. Oxford University Press (10)
  3. Springer (7)
  4. Biomed Central Ltd (5)
  5. Elsevier Inc. (5)
  6. American Association for Cancer Research (4)

More Publishers

Results (69)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic stem cell therapy in relapsed/refractory B cell lymphomas
    Meeting Abstract

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Updated results of phase 1 study of ripretinib (DCC-2618), a broad-spectrum KIT and PDGFRA inhibitor, in patients with gastrointestinal stromal tumor (GIST) by line of therapy (NCT02571036)
    Meeting Abstract

    Chi, P.; Janku, F.; Heinrich, M.; Ganjoo, K.; Gelderblom, H.; Gordon, M.; Jones, R.; Razak, A.; Trent, J.; von Mehren, M.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • A phase 1 trial of AG-270 in patients with advanced solid tumors or lymphoma with homozygous MTAP deletion
    Meeting Abstract

    Heist, R. S.; Gounder, M. M.; Postel-Vinay, S.; Wilson, F.; Garralda, E.; Do, K.; Shapiro, G. I.; Martin-Romano, P.; Wulf, G.; Cooper, M.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Immunotherapy of sarcoma
    Book Whole


    Springer (2019)

    Fulltext@MSK | Save
  • Establishing a mutually respectful environment in the workplace: A toolbox for performance excellence
    Review

    Duma, N.; Maingi, S.; Tap, W. D.; Weekes, C. D.; Thomas, C. R. Jr
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Case studies of sarcoma and MRCLS following treatment with NY-ESO-1 TCR T Cells (GSK3377794): Correlates of predictable response characteristics
    Meeting Abstract

    Van Tine, B.; D'Angelo, S.; Gyurdieva, A.; Johnson, L.; Turner, D.; Tress, J.; DeYoung, M. P.; Wu, Y.; Hasan, A.; Araujo, D.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A*02+ previously-treated and -untreated advanced metastatic/unresectable synovial sarcoma: A master protocol study design
    Meeting Abstract

    D'Angelo, S.; Blay, J. Y.; Chow, W.; Demetri, G.; Thistlethwaite, F.; Wagner, M.; Loeb, D.; Attia, S.; Razak, A.; Haanen, J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1 trial of NY-ESO-1-specific adoptive T-cell therapy with GSK3377794 in patients with advanced synovial sarcoma
    Meeting Abstract

    D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Tress, J.; DeYoung, M. P.; Hasan, A.; Wu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: Primary analysis after ≥ 15 months of follow-up from JAVELIN Merkel 200, a registrational phase 2 trial
    Meeting Abstract

    D'Angelo, S.; Lebbé, C.; Mortier, L.; Brohl, A.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G.; Hassel, J.; Kiecker, F.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • INVICTUS: A phase III, interventional, double-blind, placebo-controlled study to assess the safety and efficacy of ripretinib as ≥ 4th-line therapy in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior anticancer therapies (NCT03353753)
    Meeting Abstract

    von Mehren, M.; Serrano, C.; Bauer, S.; Gelderblom, H.; George, S.; Heinrich, M.; Schöffski, P.; Zalcberg, J.; Chi, P.; Jones, R. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save